Pipeline Launches And Global Healthcare Trends Will Unlock Growth

Published
13 Apr 25
Updated
15 Aug 25
AnalystHighTarget's Fair Value
US$68.00
28.8% undervalued intrinsic discount
15 Aug
US$48.44
Loading
1Y
-1.9%
7D
5.4%

Author's Valuation

US$68.0

28.8% undervalued intrinsic discount

AnalystHighTarget Fair Value

Shared on07 May 25
Fair value Increased 0.015%

Shared on30 Apr 25
Fair value Decreased 0.015%

AnalystHighTarget has increased revenue growth from -1.5% to -2.2%.

Shared on23 Apr 25
Fair value Increased 0.55%

Shared on16 Apr 25

AnalystHighTarget made no meaningful changes to valuation assumptions.